Construction of HPLC fingerprint of Jian'er Xiaoshi Oral Liquid and Determination of Content of Multiple Components
By optimizing the HPLC detection method and using an Agilent ZORBAX Eclipse XDB-C18 column and gradient elution technology, the problems of long detection time and poor separation of hesperidin and baicalin in Jian'er Xiaoshi Oral Liquid were solved, achieving rapid and accurate detection of multiple indicators, which is suitable for product testing and production quality control of Jian'er Xiaoshi Oral Liquid.
Patent Information
- Application Number
- CN202411802473.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2024-12-09
- Publication Date
- 2026-11-17
- Estimated Expiration
- 2044-12-09
AI Technical Summary
Existing technologies for detecting hesperidin and baicalin in Jian'er Xiaoshi Oral Liquid suffer from long detection times and poor separation, failing to meet chromatographic requirements.
An Agilent ZORBAX Eclipse XDB-C18 column was used with acetonitrile as mobile phase A and 0.1% phosphoric acid solution as mobile phase B. Gradient elution was employed, and the detection method was optimized by combining ultrasonic treatment and centrifugation steps. An HPLC fingerprint was constructed and the contents of multiple components were determined.
It achieves the detection of ingredients in Jian'er Xiaoshi Oral Liquid with short detection time, good separation, high accuracy, simple operation, and high precision, and is suitable for product testing and production quality control.
Smart Images

Figure FT_1 
Figure FT_2 
Figure FT_3
Abstract
Description
Technical Field
[0001] This invention belongs to the field of food and pharmaceutical testing technology. Specifically, it relates to a method for constructing an HPLC fingerprint of Jian'er Xiaoshi oral liquid and a method for determining the content of multiple index components. Background Technology
[0002] Jian'er Xiaoshi Oral Liquid is made from seven medicinal herbs, including Astragalus membranaceus, Atractylodes macrocephala, Ophiopogon japonicus, Citrus reticulata peel, Scutellaria baicalensis, Crataegus pinnatifida, and Raphanus sativus seeds. It has the effects of strengthening the spleen and stomach, regulating qi and promoting digestion. It is used for children's poor appetite, hot palms and soles, spontaneous sweating, fatigue, irregular bowel movements, and even anorexia and nausea caused by improper diet and damage to the spleen and stomach.
[0003] Currently, high performance liquid chromatography (HPLC) is mainly used to detect hesperidin and baicalin in Jian'er Xiaoshi oral liquid. However, the existing methods have long testing times and poor separation, failing to meet the chromatographic requirements. Summary of the Invention
[0004] The purpose of this invention is to provide a method for constructing an HPLC fingerprint of Jian'er Xiaoshi Oral Liquid and a method for determining the content of multiple components.
[0005] To achieve the objectives of this invention, in a first aspect, this invention provides a method for constructing an HPLC fingerprint spectrum of Jian'er Xiaoshi Oral Liquid and a method for determining the content of multiple index components, wherein the effective components are hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin, and the effective components are determined by HPLC and an HPLC fingerprint spectrum is constructed.
[0006] The HPLC chromatographic conditions were as follows: an Agilent ZORBAX Eclipse XDB-C18 column (4.6 mm × 250 mm, 5 µm) was used as the stationary phase (octadecylsilane-bonded silica gel); acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B; gradient elution was performed according to Table 1. Table 1 Gradient elution program
[0007] The column temperature was 32℃, the flow rate was 1 mL / min, and the detection wavelength was 242 nm.
[0008] Furthermore, the method includes the following steps: 1) Preparation of reference solutions: Take appropriate amounts of hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin reference standards, and add 50% methanol to prepare solutions containing 0.05 mg, 0.3 mg, 0.01 mg, 0.015 mg, 0.05 mg, and 0.015 mg per ml, respectively. 2) Preparation of test solution: Take 5 ml of Jian'er Xiaoshi oral liquid, put it in a 50 ml volumetric flask, add 15 ml of water, shake well, then add 25 ml of methanol, shake well, sonicate, cool, dilute with methanol to the mark, shake well, centrifuge, take the supernatant, filter, and take the filtrate to obtain the test solution. 3) Perform HPLC analysis on the reference solution and the test solution respectively: 4) Based on the HPLC detection results, an HPLC fingerprint chromatogram was constructed with hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin as the active ingredients. Baicalin was used as the reference peak. The similarity between the reference standard and the test sample was calculated using the Chinese Medicine Chromatographic Fingerprint Similarity Evaluation System (Version 2004). The content of each active ingredient was calculated from the chromatograms of the reference standard and the test sample.
[0009] Preferably, the conditions for ultrasonic treatment in step 2) are: power 250 W, frequency 50 kHz, and ultrasonic treatment for 5 minutes.
[0010] Preferably, the centrifugation conditions in step 2) are: 3000 rpm for 10 minutes.
[0011] Furthermore, hesperidin peaked at 55-65 min, baicalin at 70-80 min, sinigrin thiocyanate at 15-25 min, baicalein at 95-105 min, wogonin at 82-92 min, and wogonein at 110-120 min.
[0012] Secondly, the present invention provides the application of the method in the testing of commercially available children's digestive oral liquid products.
[0013] Thirdly, the present invention provides the application of the method in the quality control of the production process of Jian'er Xiaoshi Oral Liquid.
[0014] By employing the above technical solution, the present invention has at least the following advantages and beneficial effects: This invention establishes a fingerprint spectrum and multi-index component content determination method for Jian'er Xiaoshi Oral Liquid. This method has short detection time, good separation, accuracy, reliability, simple operation, high precision, specificity, stability and good repeatability.
[0015] The high-performance liquid chromatography method provided by this invention can simultaneously determine hesperidin, baicalin and wogonin in Jian'er Xiaoshi oral liquid. Linearity, precision, repeatability and stability tests, recovery rate test and sample content determination were carried out, providing a research basis for the quality control of this preparation. Attached Figure Description
[0016] Figure 1 This is a chromatogram of the prior art detection method of the present invention.
[0017] Figure 2 This is the chromatogram of Comparative Example 1 of the present invention.
[0018] Figure 3 This is the chromatogram of Comparative Example 2 of the present invention.
[0019] Figure 4 This is the chromatogram of Comparative Example 3 of the present invention.
[0020] Figure 5 This is a chromatogram of a preferred embodiment of the present invention.
[0021] Figure 6 This is a comparison of the fingerprint spectra of each batch of finished products with the control fingerprint spectrum in a preferred embodiment of the present invention.
[0022] Figure 7 The reference fingerprint spectrum in the preferred embodiment of the present invention includes peak 3: sinigrin thiocyanate, peak 6: hesperidin, peak 8: baicalin, peak 9: wogonin, peak 10: baicalein, and peak 11: wogonin.
[0023] Figure 8 This is a linear relationship graph of hesperidin concentration and peak area in a preferred embodiment of the present invention.
[0024] Figure 9 This is a linear relationship graph of baicalin concentration and peak area in a preferred embodiment of the present invention. Detailed Implementation
[0025] The existing HPLC detection methods for Jian'er Xiaoshi Oral Liquid are as follows: Preparation of reference solutions: Accurately weigh appropriate amounts of verbascoside, hesperidin, and baicalin reference standards, and add methanol to prepare mixed reference solutions 1 with mass concentrations of 0.0058, 0.1380, and 0.9500 mg / mL, respectively; accurately weigh appropriate amounts of verbascoside, hesperidin, baicalin, sinigrin thiocyanate, baicalein, and wogonin reference standards, and add methanol to prepare mixed reference solutions 2 with mass concentrations of 0.014, 0.055, 0.380, 0.076, 0.050, and 0.190 mg / mL, respectively.
[0026] Preparation of the test solution: Accurately measure 5 mL of Jian'er Xiaoshi Oral Liquid and place it in a 100 mL Erlenmeyer flask. Add 25 mL of methanol, sonicate (300 W power, 50 kHz frequency) for 20 min, centrifuge for 10 min, take all the supernatant and evaporate it to about 2 mL in a water bath. Add methanol to make up to 10 mL, and filter it through a 0.45 µm microporous membrane to obtain the test solution.
[0027] Chromatographic conditions: An Agilent ZORBAX SB C18 column (150 mm × 4.6 mm, 3.5 µm) was used with octadecylsilane-bonded silica gel as the packing material; acetonitrile was used as mobile phase A and 1% acetic acid solution was used as mobile phase B; gradient elution was performed (Table 2); column temperature was 30℃; flow rate was 1 mL / min; detection wavelength was 242 nm; and injection volume was 10 μL.
[0028] Table 2 Gradient elution program
[0029] Experiments revealed that the existing detection method is time-consuming and has poor separation. Figure 1 The chromatographic conditions cannot meet the requirements and need to be optimized.
[0030] In view of this, the present invention provides an improved method for constructing an HPLC fingerprint of Jian'er Xiaoshi oral liquid and a method for determining the content of multiple index components, as detailed below: Preparation of reference solutions: Accurately weigh appropriate amounts of hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin reference standards, and add 50% methanol to prepare solutions containing 0.05 mg, 0.3 mg, 0.01 mg, 0.015 mg, 0.05 mg, and 0.015 mg per ml, respectively.
[0031] Preparation of the test solution: Accurately measure 5 ml of this product and place it in a 50 ml volumetric flask. Add 15 ml of water and shake well. Then add 25 ml of methanol and shake well. Sonicate the solution (power 250 W, frequency 50 kHz) for 5 minutes. Cool the solution and dilute it to the mark with methanol. Shake well and centrifuge (speed 3000 rpm) for 10 minutes. Take the supernatant, filter it, and take the filtrate to obtain the test solution.
[0032] Chromatographic conditions: An Agilent ZORBAX EclipseXDB-C18 column (4.6 mm × 250 mm, 5 µm) was used with octadecylsilane-bonded silica gel as the packing material; acetonitrile was used as mobile phase A and 0.1% phosphoric acid solution was used as mobile phase B; gradient elution was performed (Table 1), column temperature was 32℃, flow rate was 1 mL / min, and detection wavelength was 242 nm.
[0033] Assay: Accurately pipette 10 μL each of the reference solution and the test solution into the liquid chromatograph, measure and record the chromatogram to obtain the result.
[0034] This method has a short detection time and good separation of each active ingredient.
[0035] The following examples are used to illustrate the present invention, but are not intended to limit the scope of the invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
[0036] Comparative Example 1 Reference solutions: Accurately weigh appropriate amounts of verbascoside, hesperidin, and baicalin reference standards, and add methanol to prepare mixed reference solution 1 with mass concentrations of 0.0058, 0.1380, and 0.9500 mg / mL, respectively; accurately weigh appropriate amounts of verbascoside, hesperidin, baicalin, sinigrin thiocyanate, baicalein, and wogonin reference standards, and add methanol to prepare mixed reference solution 2 with mass concentrations of 0.014, 0.055, 0.380, 0.076, 0.050, and 0.190 mg / mL, respectively. Take an appropriate amount of potassium sorbate and add methanol to prepare a reference solution (excipient reference standard) with a mass concentration of 1.501 mg / mL for later use.
[0037] Test solution: Accurately measure 5 mL of the test sample and place it in a 100 mL Erlenmeyer flask. Add 25 mL of methanol, sonicate (300 W power, 50 kHz frequency) for 20 min, centrifuge for 10 min, take all the supernatant and evaporate it in a water bath to about 2 mL, add methanol to make up to 10 mL, and filter it through a 0.45 µm microporous membrane to obtain the test solution.
[0038] Chromatographic conditions: An Agilent ZORBAX SB C18 column (150 mm × 4.6 mm, 3.5 µm) was used with octadecylsilane-bonded silica gel as the packing material; the mobile phase was acetonitrile (A) - 1% acetic acid solution (B); the flow rate was 1.0 mL / min; the detection wavelength was 242 nm; the column temperature was 30 ℃; and the injection volume was 10 μL. The gradient elution program is shown in Table 3.
[0039] Table 3 Gradient elution program
[0040] After comparison, the elution gradient was optimized based on existing detection methods, but the separation of hesperidin was found to be poor. Figure 2 (It still needs further optimization.)
[0041] Comparative Example 2 Reference solutions: Accurately weigh appropriate amounts of verbascoside, hesperidin, and baicalin reference standards, and add methanol to prepare mixed reference solution 1 with mass concentrations of 0.0058, 0.1380, and 0.9500 mg / mL, respectively; accurately weigh appropriate amounts of verbascoside, hesperidin, baicalin, sinigrin thiocyanate, baicalein, and wogonin reference standards, and add methanol to prepare mixed reference solution 2 with mass concentrations of 0.014, 0.055, 0.380, 0.076, 0.050, and 0.190 mg / mL, respectively. Take an appropriate amount of potassium sorbate and add methanol to prepare a reference solution (excipient reference standard) with a mass concentration of 1.501 mg / mL for later use.
[0042] Test solution: Accurately measure 5 mL of the test sample and place it in a 100 mL Erlenmeyer flask. Add 25 mL of methanol, sonicate (300 W power, 50 kHz frequency) for 20 min, centrifuge for 10 min, take all the supernatant and evaporate it in a water bath to about 2 mL, add methanol to make up to 10 mL, and filter it through a 0.45 µm microporous membrane to obtain the test solution.
[0043] Chromatographic conditions: An Agilent ZORBAX SB C18 column (150 mm × 4.6 mm, 3.5 µm) was used with octadecylsilane-bonded silica gel as the packing material; the mobile phase was acetonitrile (A) - 1% acetic acid solution (B); the flow rate was 1.0 mL / min; the detection wavelength was 242 nm; the column temperature was 30 ℃; and the injection volume was 10 μL. The gradient elution program is shown in Table 4.
[0044] Table 4 Gradient elution program
[0045] After comparison, the elution gradient was optimized based on the scheme in Comparative Example 1, and the results showed that the separation of hesperidin was not good. Figure 3 Meanwhile, the peak of verbascoside isoflavone glucoside was too small to be treated as a common peak and still needs further optimization.
[0046] Comparative Example 3 Reference solutions: Accurately weigh appropriate amounts of hesperidin and baicalin reference standards, and add methanol to prepare mixed reference solution 1 with mass concentrations of 0.05 and 0.05 mg / mL, respectively; accurately weigh appropriate amounts of hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin reference standards, and add methanol to prepare mixed reference solution 2 with mass concentrations of 0.05, 0.3, 0.01, 0.015, 0.05, and 0.015 mg / mL, respectively. Take an appropriate amount of potassium sorbate and add methanol to prepare a reference solution (excipient reference standard) with a mass concentration of 1.501 mg / mL for later use.
[0047] Preparation of the test solution: Accurately measure 5 ml of this product and place it in a 50 ml volumetric flask. Add 15 ml of water and shake well. Then add 25 ml of methanol and shake well. Sonicate the solution (power 250 W, frequency 50 kHz) for 5 minutes. Cool the solution and dilute it to the mark with methanol. Shake well and centrifuge (speed 3000 rpm) for 10 minutes. Take the supernatant, filter it, and take the filtrate to obtain the test solution.
[0048] Chromatographic conditions: An Agilent ZORBAX SB C18 column (150 mm × 4.6 mm, 3.5 µm) was used with octadecylsilane-bonded silica gel as the packing material; the mobile phase was acetonitrile (A)-0.1% phosphoric acid solution (B); the flow rate was 1.0 mL / min; the detection wavelength was 242 nm; the column temperature was 32 °C; and the injection volume was 10 μL. The gradient elution program is shown in Table 5.
[0049] Table 5 Gradient elution program
[0050] After comparison, the elution gradient was optimized based on the scheme of Comparative Example 2. The results showed that the separation of hesperidin was improved, but the separation of baicalin was not good. Figure 4 (It still needs further optimization.)
[0051] Example 1 Reference solutions: Accurately weigh appropriate amounts of hesperidin and baicalin reference standards, and add methanol to prepare mixed reference solution 1 with mass concentrations of 0.05 and 0.05 mg / mL, respectively; accurately weigh appropriate amounts of hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin reference standards, and add methanol to prepare mixed reference solution 2 with mass concentrations of 0.05, 0.3, 0.01, 0.015, 0.05, and 0.015 mg / mL, respectively; take an appropriate amount of potassium sorbate and add methanol to prepare a reference solution with a mass concentration of 1.501 mg / mL, for later use.
[0052] Preparation of the test solution: Accurately measure 5 ml of this product and place it in a 50 ml volumetric flask. Add 15 ml of water and shake well. Then add 25 ml of methanol and shake well. Sonicate the solution (power 250 W, frequency 50 kHz) for 5 minutes. Cool the solution and dilute it to the mark with methanol. Shake well and centrifuge (speed 3000 rpm) for 10 minutes. Take the supernatant, filter it, and take the filtrate to obtain the test solution.
[0053] Chromatographic conditions: An Agilent ZORBAX SB C18 column (150 mm × 4.6 mm, 3.5 µm) was used with octadecylsilane-bonded silica gel as the packing material; the mobile phase was acetonitrile (A)-0.1% phosphoric acid solution (B); the flow rate was 1.0 mL / min; the detection wavelength was 242 nm; the column temperature was 32 °C; and the injection volume was 10 μL. The gradient elution program is shown in Table 1.
[0054] After comparison, the elution gradient was optimized based on the scheme in Comparative Example 3, and the separation degree of each component met the requirements. Figure 5 ).
[0055] Example 2 Methodological validation was performed using the above-mentioned preparation methods for reference standards and test samples, as well as chromatographic conditions, for fingerprinting and multi-index component detection methods, as detailed below: 1. Validation of fingerprint analysis methodology 1.1 Precision Take 6 samples of this product (Jian'er Xiaoshi Oral Liquid, batch number: 215260012) and examine the consistency between the retention time and peak area of each major chromatographic peak. The results are shown in Table 6.
[0056] Table 6 Results of fingerprint precision evaluation
[0057] The results showed that the RSD of retention time was between 0.00% and 0.08%, and the RSD of chromatographic peak area was between 0.08% and 1.98%, indicating good precision.
[0058] 1.2 Repeatability Test Take 6 samples of this product (Jianer Xiaoshi Oral Liquid, batch number: 215260012) and examine the consistency between the retention time and peak area of each major chromatographic peak. The results are shown in Table 7.
[0059] Table 7 Results of fingerprint repeatability test
[0060] The results showed that the RSD of retention time was between 0.00% and 0.08%, and the RSD of chromatographic peak area was between 0.08% and 1.98%, indicating good repeatability.
[0061] 1.3 Solution stability study Accurately pipette the test solution (Jian'er Xiaoshi Oral Liquid, batch number: 215260012) and inject 10 μl at room temperature at 0, 2, 4, 6, 8, 10, 12, 24, 48, and 72 hours after preparation. Record the peak area of the sample, examine the stability of the sample solution, and calculate the relative standard deviation (RSD) (%). The results are shown in Table 8.
[0062] Table 8 Results of stability study of fingerprint spectrum solution
[0063] The results showed that the RSD of retention time was between 0.02% and 0.10%, and the RSD of chromatographic peak area was between 0.84% and 2.94%, indicating that the solution had good stability.
[0064] 1.5 Determination of the fingerprint spectrum and reference peak Comparison of the atlas ( Figure 7 Eleven common peaks were observed. According to the selection requirements for fingerprint reference peaks, peak 8, which is the chromatographic peak of baicalin, is stable, has good resolution, and has the largest peak area. Therefore, peak 8 was determined as the reference peak.
[0065] Among them, hesperidin peaked at 60 min, baicalin at 72 min, sinigrin thiocyanate at 20 min, baicalein at 99 min, wogonin at 87 min, and wogonein at 114 min.
[0066] 2. Validation of the multi-index component test methodology 2.1 Specificity Table 9 Specificity Test Results
[0067] Table 9 shows that the retention times of the hesperidin and baicalin peaks in the test sample were consistent with those of the hesperidin, baicalin, and wogonin reference standards, respectively. No corresponding peaks appeared at the positions of the hesperidin and baicalin reference standard peaks in the negative sample chromatogram, indicating no interference from the negative sample and demonstrating the good specificity of this method.
[0068] 2.2 Linear Table 10 Results of the linearity test for hesperidin Table 10 and Figure 8 The results showed that the linear relationship between the concentration and peak area of hesperidin was good in the range of 26.2926 μg / mL - 210.3408 μg / mL. The linear equation for hesperidin was y = 6148.9x + 27387, R = 0.9992.
[0069] Table 11 Results of linearity test of baicalin Table 11 and Figure 9 The results showed that the linear relationship between the concentration and peak area of baicalin was good within the range of 25.4800 μg / mL to 203.8400 μg / mL. The linear equation for baicalin was y = 11520x + 39900, R = 0.9994.
[0070] 2.3 Accuracy 2.3.1 Hesperidin recovery rate Table 12 Recovery Test
[0071] Table 12 shows that the recovery rate of hesperidin was 97.57%, within the range of 85%–110%; the RSD was 0.82%, less than 2.0%, meeting the validation requirements. This indicates that the method for content determination has good accuracy.
[0072] 2.3.2 Recovery rate of baicalin Table 13 Recovery Test
[0073] Table 13 shows that the recovery rate of baicalin was 96.36%, within the range of 85%–110%; the RSD was 1.52%, less than 2.0%, meeting the validation requirements. This indicates that the method for content determination has good accuracy.
[0074] 2.4 Precision 2.4.1 Intermediate Precision Examination Table 14 Results of intermediate precision test for hesperidin content
[0075] Table 14 shows that the RSD values of the six test solutions prepared by the two experimenters at different times were 0.10% and 0.21%, respectively; the RSD% of the intermediate precision was 1.72%, which is less than 8% and meets the requirements. This indicates that the method has good intermediate precision in determining the hesperidin content.
[0076] Table 15 Results of intermediate precision test of baicalin
[0077] The results showed that when two experimenters prepared six test solutions at different times, the RSD values were 0.12% and 0.13%, respectively; the intermediate precision RSD% was 1.02%, less than 8%, which met the requirements. This indicates that the method has good intermediate precision in detecting baicalin content.
[0078] Table 15 shows that when two experimenters prepared six test solutions at different times and using different instruments, the RSD values of hesperidin detection were 0.03% and 0.08%, respectively; both RSD values were less than 2%, meeting the requirements. This indicates good intermediate precision.
[0079] 2.5 Repeatability Test Table 16 Repeatability Study of Hesperidin Content
[0080] Table 16 shows that the RSD% of the repeatability of hesperidin content detection is 0.10, which meets the requirements.
[0081] Table 17 Repeatability Study of Baicalin Content
[0082] Table 17 shows that the RSD% of the repeatability of the baicalin content detection was 0.12, which meets the requirements.
[0083] 2.6 Solution stability study Table 18 Results of stability tests on hesperidin and baicalin in the test solution
[0084] The results in Table 18 show that, under the specified conditions, the RSD value of the peak area of hesperidin obtained within 72 hours of the test sample was 1.37%, which meets the requirements, indicating that the hesperidin in the test sample solution is relatively stable; the RSD value of the peak area of baicalin obtained within 72 hours of the test sample was 1.51%, which meets the requirements, indicating that the baicalin in the test sample solution is relatively stable.
[0085] 3. Sample Inspection Finished products were inspected using the validated testing methods described above. The test results are shown in Table 19, and the fingerprint chromatograms are shown below. Figure 6 : Table 19 Comparison of Finished Product Similarity
[0086] The results of the multi-index component content determination are shown in Table 20: Table 20 Results of Multi-Indicator Component Content Determination
[0087] Although the present invention has been described in detail above with general descriptions and specific embodiments, modifications or improvements can be made to it, which will be obvious to those skilled in the art. Therefore, all such modifications or improvements made without departing from the spirit of the present invention fall within the scope of protection claimed by the present invention.
Claims
1. A method for constructing an HPLC fingerprint of Jian'er Xiaoshi Oral Liquid and a method for determining the content of multiple components, characterized in that, The active ingredients were hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin, and the active ingredients were determined by HPLC and their HPLC fingerprints were constructed. The HPLC chromatographic conditions were as follows: an Agilent ZORBAX EclipseXDB-C18 column (4.6 mm × 250 mm, 5 µm) was used as the stationary phase (octadecylsilane-bonded silica gel); acetonitrile was used as mobile phase A, and 0.1% phosphoric acid solution was used as mobile phase B; gradient elution was performed according to Table 1. Table 1 Gradient elution program The column temperature was 32℃, the flow rate was 1 mL / min, and the detection wavelength was 242 nm. Includes the following steps: 1) Preparation of reference solutions: Take appropriate amounts of hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin reference standards, and add 50% methanol to prepare reference solutions containing 0.05 mg, 0.3 mg, 0.01 mg, 0.015 mg, 0.05 mg, and 0.015 mg per ml, respectively. 2) Preparation of test solution: Take 5 ml of Jian'er Xiaoshi oral liquid, put it in a 50 ml volumetric flask, add 15 ml of water, shake well, then add 25 ml of methanol, shake well, sonicate, cool, dilute with methanol to the mark, shake well, centrifuge, take the supernatant, filter, and take the filtrate to obtain the test solution. 3) Perform HPLC analysis on the reference solution and the test solution respectively: 4) Based on the HPLC detection results, an HPLC fingerprint chromatogram was constructed with hesperidin, baicalin, sinigrin thiocyanate, baicalein, wogonin, and wogonin as the effective components. Baicalin was used as the reference peak. The similarity between the reference standard and the test sample was compared using the chromatogram similarity evaluation system of traditional Chinese medicine chromatograms. The content of each effective component was calculated by comparing the chromatograms of the reference standard and the test sample. Step 2) The conditions for ultrasonic treatment are: power 250 W, frequency 50 kHz, and ultrasonic treatment for 5 minutes.
2. The method according to claim 1, characterized in that, Step 2) The centrifugation conditions are: 3000 rpm for 10 minutes.
3. The method according to claim 1 or 2, characterized in that, Hesperidin peaked at 55-65 min, baicalin at 70-80 min, sinigrin thiocyanate at 15-25 min, baicalein at 95-105 min, wogonin at 82-92 min, and wogonein at 110-120 min.
4. The application of the method according to any one of claims 1-3 in the testing of commercially available Jian'er Xiaoshi oral liquid products.
5. The application of the method according to any one of claims 1-3 in the quality control of the production process of Jian'er Xiaoshi Oral Liquid.
Citation Information
Patent Citations
HPLC fingerprint spectrum and multi-index quantitative establishment method of gynecological blood-nourishing menstruation-regulating pill
CN111537630A
Characteristic chromatogram of oral liquid for clearing lung and eliminating phlegm for children, construction method of characteristic chromatogram and detection method of multi-index components
CN118584018A
